Exicure XCUR
NASDAQ XCUR
$1.24 +0.22 (+21.57%)
As of: Oct 22, 2026 · 11:22 AM EDT

Exicure (XCUR) Capital Leases (2025)

Updated

Exicure (XCUR) posted Capital Leases of $26,000 for Q3 2025.

Analysis

Exicure (XCUR) Capital Leases (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,175.94 Bn 1,144.53 Bn 19.71 Bn
2 Johnson & Johnson 638.47 Bn 556.99 Bn 17.26 Bn
3 AbbVie 504.39 Bn 477.51 Bn 12.70 Bn
4 Merck 377.60 Bn 331.98 Bn 12.21 Bn
5 Novartis Ag 304.31 Bn 268.30 Bn 11.24 Bn
6 Astrazeneca 267.64 Bn 241.32 Bn 12.86 Bn
7 Amgen 242.06 Bn 197.45 Bn 7.24 Bn
8 Gilead Sciences 193.83 Bn 168.03 Bn 6.22 Bn
9 Pfizer 172.62 Bn 119.27 Bn 10.94 Bn
10 Exicure 7.81 Mn -4.70 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 26,000.00
API Access

Exicure Capital Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-leases&ticker=XCUR&period=max&api_key=YOUR_API_KEY